2023
Implementation and evaluation of an electronic health record-integrated app for postpartum monitoring of hypertensive disorders of pregnancy using patient-contributed data collection
Dullabh P, Heaney-Huls K, Chiao A, Callaham M, Desai P, Gauthreaux N, Kashyap N, Lobach D, Boxwala A. Implementation and evaluation of an electronic health record-integrated app for postpartum monitoring of hypertensive disorders of pregnancy using patient-contributed data collection. JAMIA Open 2023, 6: ooad098. PMID: 38028731, PMCID: PMC10646567, DOI: 10.1093/jamiaopen/ooad098.Peer-Reviewed Original ResearchElectronic health recordsHypertensive disordersRemote patient monitoring programPostpartum monitoringLocal clinical championsClinical championsPatient involvementIntegration standardsKey observationPilot interventionEHR developersClinician usersHealth recordsClinical workflowRemote monitoringDisordersPregnancyAppsSmartphone applicationInterventionData collectionPatientsDevelopersUsersUsabilityExperiences with Cyclical User-Centered Design for Patient and Clinician Facing Medication Reconciliation mHealth Applications.
Polomoff C, Jeffery S, Agresta T, Bektashev S, Tran R, Frazier W, Demurjian S, O'Dell J, Sinha S, Kashyap N. Experiences with Cyclical User-Centered Design for Patient and Clinician Facing Medication Reconciliation mHealth Applications. AMIA Annual Symposium Proceedings 2023, 2022: 874-883. PMID: 37128468, PMCID: PMC10148378.Peer-Reviewed Original Research
2022
Where Do Real-Time Prescription Benefit Tools Fit in the Landscape of High US Prescription Medication Costs? A Narrative Review
Wong R, Mehta T, Very B, Luo J, Feterik K, Crotty B, Epstein J, Fliotsos M, Kashyap N, Smith E, Woreta F, Schwartz J. Where Do Real-Time Prescription Benefit Tools Fit in the Landscape of High US Prescription Medication Costs? A Narrative Review. Journal Of General Internal Medicine 2022, 38: 1038-1045. PMID: 36441366, PMCID: PMC10039141, DOI: 10.1007/s11606-022-07945-z.Peer-Reviewed Original ResearchConceptsMedication costsElectronic clinical decision support toolPocket medication costsPrescription medication costsPoor patient adherenceWorse clinical outcomesClinical decision support toolUS healthcare costsPocket cost informationElectronic health recordsPharmacologic treatmentClinical outcomesPatient adherencePrescription medicationsHealthcare costsPatientsNarrative reviewHealth systemMedicaid ServicesLimited evidenceHealth recordsHealthcare systemFinancial burdenAdherenceMultiple factors
2021
Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial
Shah T, McCarthy M, Nasir I, Archer H, Ragheb E, Kluger J, Kashyap N, Paredes C, Patel P, Lu J, Kandel P, Song C, Khan M, Ul Haq F, Ahmad R, Howes C, Cambi B, Lancaster G, Cleman M, Dela Cruz CS, Parise H, Lansky A. Design and rationale of the colchicine/statin for the prevention of COVID-19 complications (COLSTAT) trial. Contemporary Clinical Trials 2021, 110: 106547. PMID: 34461322, PMCID: PMC8397504, DOI: 10.1016/j.cct.2021.106547.Peer-Reviewed Original ResearchConceptsHospitalized COVID-19 patientsCOVID-19 patientsStandard of careElectronic health recordsComplications TrialSevere COVID-19 diseaseWorld Health Organization (WHO) ordinal scaleVenous thromboembolic eventsHealth recordsCombination of colchicineRates of morbidityCOVID-19 diseaseCost-effective treatmentPrimary endpointRespiratory failureThromboembolic eventsClinical improvementMyocardial injuryPragmatic trialClinical trialsPatientsEvent ascertainmentHealth NetworkRosuvastatinTrials